Biosig Technologies (NASDAQ:STEX – Get Free Report) is one of 28 publicly-traded companies in the “Surgical, Medical, And Dental Instruments And Supplies” industry, but how does it weigh in compared to its rivals? We will compare Biosig Technologies to similar businesses based on the strength of its analyst recommendations, earnings, profitability, valuation, risk, dividends and [...]
Darden Restaurants (NYSE:DRI – Get Free Report)‘s stock had its “buy” rating restated by analysts at BTIG Research in a research note issued on Friday,Benzinga reports. They currently have a $225.00 price target on the restaurant operator’s stock. BTIG Research’s target price points to a
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) had its target price lifted by Needham & Company LLC from $10.00 to $12.00 in a note issued to investors on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. Needham & Company LLC’s price
Darden Restaurants (NYSE:DRI – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at BTIG Research in a report released on Friday,Benzinga reports. They currently have a $225.00 target price on the restaurant operator’s stock. BTIG Research’s target price would suggest a
Park Avenue Securities LLC boosted its stake in shares of Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA – Free Report) by 2.5% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 831,843 shares of the company’s stock after acquiring an additional
